Deep Track Biotechnology Master Fund, Ltd.

Insider Reports History

Location
George Town, Cayman Islands
Signature
Deep Track Biotechology Master Fund, Ltd. /s/ David Kroin, Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deep Track Biotechnology Master Fund, Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
DYNAVAX TECHNOLOGIES CORP 10%+ Owner Common Stock, par value $0.001 per share 15,726,349 $166,542,035 $10.59 22 Aug 2025 Direct
LB PHARMACEUTICALS INC 10%+ Owner Common Stock 2,686,138 12 Sep 2025 Direct
LB PHARMACEUTICALS INC 10%+ Owner Common Stock 666,666 12 Sep 2025 By Deep Track Special Opportunities Fund, LP
LB PHARMACEUTICALS INC 10%+ Owner Series C Preferred Stock 0 12 Sep 2025 Direct

Insider Reports Filed by Deep Track Biotechnology Master Fund, Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LBRX LB PHARMACEUTICALS INC 12 Sep 2025 4 +$39,999,990 4 10%+ Owner 16 Sep 2025, 18:09
LBRX LB PHARMACEUTICALS INC 10 Sep 2025 0 $0 3 10%+ Owner 10 Sep 2025, 19:33
DVAX DYNAVAX TECHNOLOGIES CORP 21 Aug 2025 2 -$22,351,598 4 10%+ Owner 22 Aug 2025, 20:49
DVAX DYNAVAX TECHNOLOGIES CORP 22 Oct 2024 0 $0 3 10%+ Owner 24 Oct 2024, 16:05